Navigation Links
Meritage Pharma, Inc. Announces Company Formation and $22.5M Series A Financing
Date:6/16/2008

tements

Meritage Pharma cautions you that statements included in this press release that are not a description of historical facts may be forward-looking statements. The inclusion of forward-looking statements should not be regarded as a representation by Meritage Pharma that any of its plans will be achieved. Actual results may differ materially from those set forth in this press release due to the risks and uncertainties inherent in Meritage Pharma's business including, without limitation, statements about: difficulties or delays in developing, obtaining regulatory approval, manufacturing and commercializing its products; unexpected performance or side effects of its products that could delay or prevent development or commercialization; the scope and validity of patent protection for its products; competition from other pharmaceutical companies; and its ability to obtain additional financing to support its operations. All forward-looking statements are qualified in their entirety by this cautionary statement and Meritage Pharma undertakes no obligation to revise or update this press release to reflect events or circumstances after the date hereof.


'/>"/>
SOURCE Meritage Pharma, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. GeoPharma, Inc. Receives FDA Approval to Manufacture and Distribute Carprofen
2. Novo Nordisk Inc. Announces Exclusive Agreement With Sciele Pharma, Inc. to Market Prandin(R)
3. China Biopharma, Inc. Announces New Plan of Operation
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
6. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
7. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
8. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
9. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
10. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
11. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...swire-FirstCall/ -- BioMarin Pharmaceutical,Inc. ...kkis, its Chief Medical,Officer will retire from ...,decided to leave his position with the company to...to personal endeavors related to rare diseases. D...e company for the foreseeable,future. , "I...
(Date:11/21/2008)...ewswire/ -- MichBio, the association for,Michigan...iences professionals,and service providers to its...his week at the Rock Financial ShowPlace in Novi, ...ring of Michigan bioscience industry professionals...ibitors. The 2009 Expo is,planned for November 17...
(Date:11/21/2008).... 21 Eli Lilly and,Comp...d (Nasdaq: IMCL ) today,announced the successfu...fer,by Lilly,s wholly-owned subsidiary, Alaska Ac... of ImClone at a price of $70.00 per share in cash...ursday, November 20, 2008. , The depositary...
(Date:11/21/2008)...e-FirstCall/ -- LCA-Vision Inc. (Nasdaq:, LCAV )...rvices under the,LasikPlus(R) brand, today announ...he position of Chief Financial Officer on a perman...rezze, who has served as interim CFO since June,2...agement team as Senior Vice,President of Finance ...
Breaking Biology Technology:BioMarin Announces the Planned Retirement of Dr. Emil Kakkis, Chief Medical Officer 2BioMarin Announces the Planned Retirement of Dr. Emil Kakkis, Chief Medical Officer 3BioMarin Announces the Planned Retirement of Dr. Emil Kakkis, Chief Medical Officer 4MichBio Expo Draws Nearly 500 Professionals; Career Day Raises Profile 2MichBio Expo Draws Nearly 500 Professionals; Career Day Raises Profile 3Lilly Completes Cash Tender Offer for ImClone Systems 2Lilly Completes Cash Tender Offer for ImClone Systems 3LCA-Vision Names Michael J. Celebrezze CFO 2LCA-Vision Names Michael J. Celebrezze CFO 3LCA-Vision Names Michael J. Celebrezze CFO 4
...t know something that Alan Greenspan doesn,t becau... second quarter of 2007, according to the latest ...ogy hiring. , ,The report, published after former ...recast a possible recession in the second half of ...o add full-time IT staff in the second quarter - t...
...he Wisconsin Technology Network , Gov. Jim Doyle...nsin System fueling our state,s economy. The gove...e UW System is one of the best in the country. In ...e willing to innovate and evolve, something it has...UW System and the Board of Regents have shown th...
...wledging that a return to profitability won,t happ...ted an annual net loss of $258.5 million, or $7.67...everal executives resigned in the wake of financia...goodwill impairment, trade name impairment, and re... share, compares to a net loss of $2.7 million, or...
...enator Robert Cowles admitted his crystal ball ma...about the state of Wisconsin,s information technol...tion of the Legislative Audit Bureau,s pending r...a software executive, isn`t sure the worst news is... audit on state IT projects should be a catalyst f...
Other Biology Technology:UW System must remove barriers to innovation 2UW System must remove barriers to innovation 3UW System must remove barriers to innovation 4Merge Healthcare suffers $258M loss in `06 2Is the worst over for state technology failures? 2
(Date:11/20/2008)... , Aging we are all doing it. It is relentless a...nd magicians, philosophers and science fiction wri...ed all their various arts in the pursuits of "turn... with a span of a century to our name, at most. ,...actors that determine life span still elude us? ,...
(Date:11/19/2008)... SO-What? At the time of birth, mouse ovaries ...around which primordial follicles are forming. Thi...population of oocytes and follicles and instigates... fail to form, the result is oocyte demise, yet oo...t. Several factors key to follicular formation and...
(Date:11/19/2008)... Scientists at St. Jude Children,s Research Hospi...e of the body,s enzyme workhorses called calpains....ins function in many cellular processes, including...maged cells, insulin secretion, and brain cell and...f responsibilities is that defective or overactive...
(Date:11/19/2008)... Here is the latest American Chemical Society (AC..., 36 peer-reviewed journals and Chemical & Engine... or the American Chemical Society as the source fo...TE RELEASE EXCEPT ARTICLE #5, which is embargoed f..., , ARTICLE #1 FOR IMMEDIATE RELEASE , Microc...
Breaking Biology News(10 mins):Fountain of Youth to be found in the anthill? 2Fountain of Youth to be found in the anthill? 3Fountain of Youth to be found in the anthill? 4December 2008 highlights from Biology of Reproduction 2New insight into the controls on a go-to enzyme 2New insight into the controls on a go-to enzyme 3American Chemical Society's Weekly PressPac -- Nov. 19, 2008 2American Chemical Society's Weekly PressPac -- Nov. 19, 2008 3American Chemical Society's Weekly PressPac -- Nov. 19, 2008 4American Chemical Society's Weekly PressPac -- Nov. 19, 2008 5American Chemical Society's Weekly PressPac -- Nov. 19, 2008 6American Chemical Society's Weekly PressPac -- Nov. 19, 2008 7American Chemical Society's Weekly PressPac -- Nov. 19, 2008 8Healthcare Technologies Reports 2007 Nine Months 26 Third Quarter Results 1926 1Healthcare Technologies Reports 2007 Nine Months 26 Third Quarter Results 1926 2Healthcare Technologies Reports 2007 Nine Months 26 Third Quarter Results 1926 3Sleep Problems Plague the Older Set 6837 1Sleep Problems Plague the Older Set 6837 2Sleep Problems Plague the Older Set 6837 3NACO Bows to Activists Pressure on AIDS Treatment in India Says AHF 6835 1NACO Bows to Activists Pressure on AIDS Treatment in India Says AHF 6835 2NACO Bows to Activists Pressure on AIDS Treatment in India Says AHF 6835 3People with rare type of memory loss still sensitive to others study shows 6831 1People with rare type of memory loss still sensitive to others study shows 6831 2People with rare type of memory loss still sensitive to others study shows 6831 3
...ry signaling molecule involved in immune response ...nk what they are doing" in creating drugs based on... the Oct. 1 issue of the Journal of Immunology, re...Champaign unveiled the crystal structure of mouse ...). , They found a distinct highly structured loop...
...ish-brown crescents below your eyes. If you don,t ...off infection, the muscles can,t regenerate as qui... can,t focus on the road. You also gain things: a ...od pressure, and heart problems. Indeed, the effec...e sleep scientists liken lifetime sleep debt to a ...
...infectious disease today. It is estimated that two...ation--are chronically infected without active sym...e diagnosed annually, resulting in two million dea...sed by a microbe called Mycobacterium tuberculosis...ar how exactly this happens. Ludovic Tailleux, Oli...
...ed system to easilymonitor the levels of glucose i...y published today in the open access journal BMC M... GRIP, a computersoftware that assists in the moni..., saves nurses time and effort and is moreefficien...nyintensive care units (ICUs). Monitoring blood gl...
Other Biology News:Molecular research suggest shift needed in how some drugs are created 2Clocking in Pillow Time without the Pillow 2Clocking in Pillow Time without the Pillow 3How does Mycobacterium tuberculosis infect the lung? 2
hypertension-related calcium-regulated gene, mRNA
Human PLUNC MAb (Clone 252512)
Rabbit polyclonal to GRASP1 ( Abpromise for all tested applications). Antigen: Synthetic peptide corresponding to amino acid residues from the C terminal region of rat GRASP1, conjugated to keyh
Homo sapiens CDC23 (cell division cycle 23, yeast, homolog),
Biology Products: